CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ 289,068	$ 4	$ 372,460	$ (83,396)
Beginning balance, shares at Dec. 31, 2022		39,377,222
Vesting of restricted stock	0	$ 0	0	0
Vesting of restricted stock, shares		107,181
Stock-based compensation expense	2,682	$ 0	2,682	0
Net loss	(9,085)	0	0	(9,085)
Ending balance at Mar. 31, 2023	282,665	$ 4	375,142	(92,481)
Ending balance, shares at Mar. 31, 2023		39,484,403
Beginning balance at Dec. 31, 2022	289,068	$ 4	372,460	(83,396)
Beginning balance, shares at Dec. 31, 2022		39,377,222
Net loss	(16,645)
Ending balance at Jun. 30, 2023	278,008	$ 4	378,045	(100,041)
Ending balance, shares at Jun. 30, 2023		39,628,764
Beginning balance at Mar. 31, 2023	282,665	$ 4	375,142	(92,481)
Beginning balance, shares at Mar. 31, 2023		39,484,403
Vesting of restricted stock	0	$ 0	0	0
Vesting of restricted stock, shares		107,093
Stock-based compensation expense	2,845	$ 0	2,845	0
Exercise of stock options	58	$ 0	58	0
Exercise of stock options, shares		37,268
Net loss	(7,560)	$ 0	0	(7,560)
Ending balance at Jun. 30, 2023	278,008	$ 4	378,045	(100,041)
Ending balance, shares at Jun. 30, 2023		39,628,764
Beginning balance at Dec. 31, 2023	269,085	$ 4	383,301	(114,220)
Beginning balance, shares at Dec. 31, 2023		40,104,937
Vesting of restricted stock	0	$ 0	0	0
Vesting of restricted stock, shares		82,339
Stock-based compensation expense	2,223	$ 0	2,223	0
Exercise of stock options	49	$ 0	49	0
Exercise of stock options, shares		65,592
Net loss	(7,856)	$ 0	0	(7,856)
Ending balance at Mar. 31, 2024	263,501	$ 4	385,573	(122,076)
Ending balance, shares at Mar. 31, 2024		40,252,868
Beginning balance at Dec. 31, 2023	269,085	$ 4	383,301	(114,220)
Beginning balance, shares at Dec. 31, 2023		40,104,937
Net loss	(18,563)
Ending balance at Jun. 30, 2024	256,714	$ 4	389,493	(132,783)
Ending balance, shares at Jun. 30, 2024		40,703,449
Beginning balance at Mar. 31, 2024	263,501	$ 4	385,573	(122,076)
Beginning balance, shares at Mar. 31, 2024		40,252,868
Vesting of restricted stock	0	$ 0	0	0
Vesting of restricted stock, shares		80,643
Stock-based compensation expense	2,608	$ 0	2,608	0
Exercise of stock options	1,312	$ 0	1,312	0
Exercise of stock options, shares		369,938
Net loss	(10,707)	$ 0	0	(10,707)
Ending balance at Jun. 30, 2024	$ 256,714	$ 4	$ 389,493	$ (132,783)
Ending balance, shares at Jun. 30, 2024		40,703,449